VANCOUVER, British Columbia, Oct. 11, 2012 /PRNewswire/ -- Insiderslab.com has issued insider trading reports and Equity Research for the following companies: Yum! (NYSE:YUM), General Electric (NYSE:GE), Bristol Myers Squibb (NYSE:BMY), United States Steel (NYSE:X), Costco (NASDAQ:COST), and Corning (NYSE:GLW).
(Read full report by clicking the link below, you may need to copy and paste the full link to your browser.)
Yum! Brands, Inc. (NYSE:YUM): On October 9, Yum!, the parent company of Taco Bell, KFC and Pizza Hut restaurant brands, reported its third quarter 2012 EPS rose 19% year-over-year, excluding Special Items. The company also forecasts its EPS growth for full year 2012 to be at least 13%, excluding Special Items. In particular, Yum! announced its operating profit in China division was US$374 million for the third quarter ended September 8, 2012, up 24% from the same quarter of 2011. Yum! plans to open at least 750 stores in China by the end of this year, compared with its prior forecast of at least 700. Yum! will also spend approximately US$100 million in the near future to expand in India, including the addition of 100 outlets in the country this year. On Wednesday, Yum! shares ended higher by 8.04% to US$70.99 on over 18.93 million shares, which was 5.8 times more than usual. Share prices of Yum! have traded as high as US$74.44 per share and as low as US$50.60 in the past 52 weeks. Investors may want to find out how Yum! insiders like CEOs, CFOs and Directors are thinking about the future of the company. Check this insider trade report for YUM here.
Read Full Report: http://www.insiderslab.com/PR3/101112B/YUM/Yum.pdf
General Electric Company (NYSE:GE): In the last three months, General Electric Company (NYSE:GE) officials have sold US$3.78 million in shares, while others have purchased US$408,800 worth. By the end of Wednesday's trading, shares of General Electric crossed below the 50-day moving average and slipped 0.84% to close at US$22.43. General Electric's 52-week range remained as US$14.68 to US$23.18 with its market capitalization touching US$236.83 billion. Its price, as of the latest close, was up 53% compared with the 52-week low and was 3% below the 52-week high. There were 32.78 million shares of General Electric exchanging hands as compared with its average daily volume of 45.82 million shares. Since General Electric insiders such as CEOs, CFOs and Directors have better access to company non-public information, Insiderslab.com thinks that investors would be wise to pay close attention to their stock trading behaviors. Check this insider trade report for GE here.
Read Full Report: http://www.insiderslab.com/PR3/101112B/GE/GeneralElectric.pdf
Bristol Myers Squibb Co. (NYSE:BMY): Insiderslab.com found company Director, James M. Cornelius, sold a total of 20,000 shares on October 2 and October 3 for about US$674,100. Disclose date: October 4. In the last three months, company insiders have sold a total of US$20.44 million in shares, which ranged in price from US$31.56 to US$36.07 each, according to insider trading report. Bristol Myers Squibb Co. (NYSE:BMY) and Sanofi announced on October 3 that the companies have revised their long-term alliance following the loss of exclusivity of Plavix® and Avapro®/Avalide® in many major markets. As per the terms of the revised agreement, Bristol Myers Squibb will return Sanofi's rights to Plavix and Avapro/Avalide in all markets worldwide, excluding Plavix in the U.S. and Puerto Rico. In addition, Bristol Myers Squibb will receive royalty payments on Sanofi's sales of branded and unbranded Plavix worldwide, with the exception of the U.S. and Puerto Rico, and on sales of branded and unbranded Avapro/Avalide worldwide, in each case through 2018. What's more, Bristol Myers Squibb will receive a terminal payment of US$200 million from Sanofi in December 2018. Moreover, the biopharmaceutical company is scheduled to release its third quarter results on Wednesday, October 24, 2012. Shares of Bristol Myers Squibb ended higher by 0.09% to US$33.26 on over 10.61 million shares, compared to its average volume of 9.88 million shares. In the past 52 weeks, BMY has traded within a range of US$30.10 - US$36.34. Insiderslab.com refers insider trading data to investors as Bristol Myers Squibb insiders like CEOs, CFOs, and Directors have a better understanding about the company's prospects. Check this insider trade report for BMY here.
Read Full Report: http://www.insiderslab.com/PR3/101112B/BMY/BristolMyersSquibb.pdf
Today Insiderslab.com also observed abnormal trade volume for the following companies; insiders may involve trading in these companies. It will take some time for insiders to report their trades. Read these reports and add these companies into your Insider Trade Radar.
United States Steel Corporation (NYSE:X):
Read Full Report: http://www.insiderslab.com/PR3/101112B/X/UnitedStatesSteel.pdf
Costco Wholesale Corporation (NASDAQ:COST):
Read Full Report: http://www.insiderslab.com/PR3/101112B/COST/Costco.pdf
Corning Incorporated (NYSE:GLW):
Read Full Report: http://www.insiderslab.com/PR3/101112B/GLW/Corning.pdf
Insider Filing Source Reference: All observations, analysis and reports are based on public information released by the U.S. Securities and Exchange Commission.
Insiderslab.com covers insider trade data in major stock markets in the U.S., Hong Kong, Mainland China, and Singapore. Insiderslab.com features a team of experienced data analysts striving to provide the investment community with the tools, software, and data necessary to carry out more effective investment research.
Please visit insiderslab.com/disclaimers/disclaimers.php for details.
SOURCE Insiderslab.com; Insiders.hk